Skip to content

Pilot Study of Vedic Medicine for Type 2 Diabetes

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00065650
Enrollment
60
Registered
2003-07-31
Start date
2003-07-31
Completion date
2004-01-31
Last updated
2015-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Diabetes Mellitus Type 2, Vedic medicine, Ayurveda, Transcendental Meditation

Brief summary

The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.

Detailed description

Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.

Interventions

DRUGVedic Medicine

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Kaiser Permanente members * Newly diagnosed type 2 Diabetes * Baseline glycosylated hemoglobin level of 6.0-7.9.

Exclusion criteria

* Pregnancy or nursing mother * Currently taking warfarin * Diagnosis of psychotic disorder or recent hospitalization for depression * Unable to comply with or attend treatment sessions

Design outcomes

Primary

MeasureTime frame
HbA1C3 months

Secondary

MeasureTime frame
Fasting Glucose3 and 6 months
Lipids3 and 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026